| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/17/2023 | Quince Therapeutics, Inc. | CRTX | Purchase | Common Stock | 24.8k | $1.29 | $31.9k | By Blue Devil Trust dated 12/03/2010 | 08/15/2023 |
| 08/16/2023 | Quince Therapeutics, Inc. | CRTX | Purchase | Common Stock | 117.3k | $1.29 | $151.4k | By Blue Devil Trust dated 12/03/2010 | 08/15/2023 |
| 08/15/2023 | Quince Therapeutics, Inc. | CRTX | Purchase | Common Stock | 107.9k | $1.32 | $142.4k | By Blue Devil Trust dated 12/03/2010 | 08/15/2023 |
| 05/24/2023 | Quince Therapeutics, Inc. | CRTX | Grant | Stock Option (right to buy) | 27k | $1.58 | $42.7k | | 05/24/2023 |
| 06/08/2022 | Quince Therapeutics, Inc. | CRTX | Grant | Stock Option (right to buy) | 27k | $3.23 | $87.2k | | 06/08/2022 |
| 06/01/2022 | Lucira Health, Inc. | LHDX | Grant | Stock Option (right to buy) | 59.5k | $1.85 | $110k | | 06/01/2022 |
| 05/24/2022 | Applied Molecular Transport Inc. | AMTI | Grant | Stock Option (Right to Buy) | 20k | $3.13 | $62.6k | | 05/24/2022 |
| 05/23/2022 | Applied Molecular Transport Inc. | AMTI | Purchase | Common Stock | 33.5k | $3.26 | $109.2k | By Trust | 05/20/2022 |
| 05/20/2022 | Applied Molecular Transport Inc. | AMTI | Purchase | Common Stock | 33k | $3.08 | $101.6k | By Trust | 05/20/2022 |
| 05/19/2022 | Quince Therapeutics, Inc. | CRTX | Grant | Common Stock | 200k | $0.00 | $0 | By David A. Lamond Trust dated 2006 | 05/19/2022 |
| 06/16/2021 | Quince Therapeutics, Inc. | CRTX | Grant | Stock Option (right to buy) | 11k | $50.56 | $557.6k | | 06/16/2021 |
| 05/18/2021 | Applied Molecular Transport Inc. | AMTI | Grant | Stock Option (Right to Buy) | 15.2k | $47.01 | $713.4k | | 05/18/2021 |
| 04/06/2021 | Applied Molecular Transport Inc. | AMTI | Purchase | Common Stock | 25k | $42.00 | $1M | By Trust | 04/06/2021 |
| 03/24/2021 | Quince Therapeutics, Inc. | CRTX | Purchase | Common Stock | 50k | $33.77 | $1.7M | By Blue Devil Trust dated 12/03/2010 | 03/24/2021 |
| 03/04/2021 | Quince Therapeutics, Inc. | CRTX | Purchase | Common Stock | 16.6k | $34.28 | $569.8k | By Blue Devil Trust dated 12/03/2010 | 03/04/2021 |
| 03/04/2021 | Quince Therapeutics, Inc. | CRTX | Purchase | Common Stock | 13.3k | $35.00 | $465.8k | By Blue Devil Trust dated 12/03/2010 | 03/04/2021 |
| 03/04/2021 | Quince Therapeutics, Inc. | CRTX | Purchase | Common Stock | 16k | $36.34 | $580.3k | By Blue Devil Trust dated 12/03/2010 | 03/04/2021 |
| 03/04/2021 | Quince Therapeutics, Inc. | CRTX | Purchase | Common Stock | 4.1k | $36.86 | $151.1k | By Blue Devil Trust dated 12/03/2010 | 03/04/2021 |
| 03/04/2021 | Quince Therapeutics, Inc. | CRTX | Gift | Common Stock | 1.5M | $0.00 | $0 | By David A. Lamond Trust dated 2006 | 03/04/2021 |
| 02/09/2021 | Lucira Health, Inc. | LHDX | Conversion | Series C Preferred Stock | 92.8k | $0.00 | $0 | See footnote | 02/09/2021 |
| 02/09/2021 | Lucira Health, Inc. | LHDX | Conversion | Series B Preferred Stock | 53.6k | $0.00 | $0 | See footnote | 02/09/2021 |
| 02/09/2021 | Lucira Health, Inc. | LHDX | Conversion | Common Stock | 92.8k | $0.00 | $0 | See footnote | 02/09/2021 |
| 02/09/2021 | Lucira Health, Inc. | LHDX | Conversion | Common Stock | 53.6k | $0.00 | $0 | See footnote | 02/09/2021 |
| 06/09/2020 | Applied Molecular Transport Inc. | AMTI | Conversion | Common Stock | 914.6k | $0.00 | $0 | By Trust | 06/09/2020 |
| 06/09/2020 | Applied Molecular Transport Inc. | AMTI | Grant | Common Stock | 71.4k | $14.00 | $1M | By Trust | 06/09/2020 |
| 06/09/2020 | Applied Molecular Transport Inc. | AMTI | Conversion | Series C Preferred Stock | 1 | $0.00 | $0 | By Trust | 06/09/2020 |
| 06/08/2020 | Quince Therapeutics, Inc. | CRTX | Grant | Stock Option (Right to Buy) | 11k | $41.73 | $460.2k | | 06/08/2020 |
| 06/04/2020 | Quince Therapeutics, Inc. | CRTX | Purchase | Common Stock | 13.6k | $42.13 | $573.4k | By Blue Devil Trust dated 12/03/2010 | 06/04/2020 |
| 06/04/2020 | Quince Therapeutics, Inc. | CRTX | Purchase | Common Stock | 10.6k | $43.32 | $461k | By Blue Devil Trust dated 12/03/2010 | 06/04/2020 |
| 06/04/2020 | Quince Therapeutics, Inc. | CRTX | Purchase | Common Stock | 24.9k | $43.88 | $1.1M | By Blue Devil Trust dated 12/03/2010 | 06/04/2020 |
| 05/19/2020 | Quince Therapeutics, Inc. | CRTX | Purchase | Common Stock | 400 | $54.09 | $21.6k | By Blue Devil Trust dated 12/03/2010 | 05/15/2020 |
| 05/19/2020 | Quince Therapeutics, Inc. | CRTX | Purchase | Common Stock | 5.9k | $55.42 | $327.3k | By Blue Devil Trust dated 12/03/2010 | 05/15/2020 |
| 05/19/2020 | Quince Therapeutics, Inc. | CRTX | Purchase | Common Stock | 32.9k | $56.42 | $1.9M | By Blue Devil Trust dated 12/03/2010 | 05/15/2020 |
| 05/15/2020 | Quince Therapeutics, Inc. | CRTX | Purchase | Common Stock | 1.3k | $46.30 | $58.5k | By Blue Devil Trust dated 12/03/2010 | 05/15/2020 |
| 05/15/2020 | Quince Therapeutics, Inc. | CRTX | Purchase | Common Stock | 985 | $48.37 | $47.6k | By Blue Devil Trust dated 12/03/2010 | 05/15/2020 |
|